The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Stephanie Lira discussing scaling operations in theranostics clinical research. There has been tremendous ...

The 2026 PSMA & Beyond conference featured a session on challenges of radioligand therapy and a presentation by Dr. Michael Hofman discussing the expansion of the theranostic dream. Only 8 years ago, ...

Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) describes a new class of radiopharmaceuticals, named radiohybrids (rh), that offer a ...

来自某研究团队（作者单位未明确）的病例报告显示，针对传统疗法无效的转移性去势抵抗性前列腺癌(mCRPC)患者，采用放射性配体疗法177Lu-PSMA（前列腺特异性膜抗原靶向镥-177）进行10个周期治疗后，患者PSA水平从358 ng/ml显著下降并伴随骨痛缓解。该研究证实了 ...

CHICAGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics ...

Prevalence of residual tumor in the prostate after contemporary systemic therapy. Effect of VERU-111, a novel oral inhibitor of α and β tubulin, on tumor growth in the human castration-resistant ...

PHILADELPHIA - Research presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates for the first time the benefit of providing earlier ...

SYDNEY, Australia, March 03, 2023 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of radiopharmaceutical products for both diagnostic and therapeutic ...

THE WOODLANDS, Texas--(BUSINESS WIRE)--Fuzionaire Diagnostics, Inc. announced today that it has changed its name to Fuzionaire Theranostics, Inc. (“Fuzionaire Tx”). Originally directed to make ...

To further elucidate the role of PSMA in oral squamous cell carcinoma, we evaluated the expression pattern of PSMA in a series of oral squamous cell carcinoma by immunohistochemistry and correlated ...

In an interview with CURE®, Dr. Phillip J. Koo defines what theranostics is, discusses the treatment’s potential and answers questions patients may have regarding its safety. There’s a tremendous ...

NORTH BILLERICA, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH) is committed to improving patient outcomes through diagnostics, radiotherapeutics and ...